Transgene, based in Strasbourg, is a biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. Transgene has bio-manufacturing capacities for viral-based vectors and technologies available for out-licensing.